Trademark: 86008550
Word
MESOBLAST
Status
Registered
Status Code
702
Status Date
Tuesday, May 5, 2020
Serial Number
86008550
Registration Number
4494438
Registration Date
Tuesday, March 11, 2014
Mark Type
4000
Filing Date
Friday, July 12, 2013
Published for Opposition
Tuesday, December 24, 2013

Trademark Owner History
Mesoblast Limited - Original Registrant

Classifications
5 Pharmaceutical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; veterinary preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; biotechnology preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; medical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluids, namely, cultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes but not including embryonic stem cells; human cells including stem cells for medical or clinical use but not embryonic stem cells; animal cells including stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatment, reconstruction and repair of tissue but not including preparations for embryonic stem cells
42 Scientific, medical research, clinical research, pharmaceutical research and development, advisory and consultancy services in the field of T-cell production, T-cell immunotherapy, cell culture devices, tissue engineering for cellular applications for humans and animals, stem cell banking, tissue banking, drug discovery, vaccine screening, cell culture methods, cell expansion technology including stem cell expansion technology, cellular therapies including stem cell therapies and cellular transplants; none of the aforementioned services relating to embryonic stem cells

Trademark Events
Mar 11, 2023
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
May 5, 2020
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
May 5, 2020
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
May 5, 2020
Case Assigned To Post Registration Paralegal
Mar 11, 2020
Teas Section 8 & 15 Received
Mar 11, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 25, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 11, 2014
Registered-Principal Register
Dec 24, 2013
Official Gazette Publication Confirmation E-Mailed
Dec 24, 2013
Published For Opposition
Dec 4, 2013
Notification Of Notice Of Publication E-Mailed
Nov 19, 2013
Law Office Publication Review Completed
Nov 19, 2013
Assigned To Lie
Oct 29, 2013
Approved For Pub - Principal Register
Oct 29, 2013
Examiner's Amendment Entered
Oct 29, 2013
Notification Of Examiners Amendment E-Mailed
Oct 29, 2013
Examiners Amendment E-Mailed
Oct 29, 2013
Examiners Amendment -Written
Oct 25, 2013
Assigned To Examiner
Jul 19, 2013
New Application Office Supplied Data Entered
Jul 16, 2013
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24